1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Population characteristics
Baseline Characteristics n = 228 Sex (female) (No.) (%) 141 (61.8%) Age (median) (IQR) (yr) 49.0 (38.4–64.1) Curaçao criteria (No.) (%) Epistaxis 209 (91.7%) Telangiectasias 219 (96.1%) Arteriovenous malformations 163 (71.5%) Family history 197 (86.4%) Curaçao criteria (3 of 4) (No.) (%) 90 (39.5%) Curaçao criteria (4 of 4) (No.) (%) 126 (55.3%) CTA (No.) (%) 24 (10.5%) MRA (No.) (%) 203 (89.0%) Cerebral angiography (No.) (%) 36 (15.8%) BVM (No.) (%) 60 (26.3%) AVM (No.) (%) 39 (17.1%) IA 33 (14.5%)